Replies to post #3216 on RedHill Biopharma Ltd (RDHL)

[midastouch017]

1) why aren’t we much higher?

Disappointment from company lack of performance
coupled with general bio underperformance:

Big-name biotech hedge funds have_been_hammered_ this_ year:

https://www.wsj.com/articles/hedge-funds-suffer-big-losses-on-biotech-rout-11638727155
Quote:
Perceptive Advisors, a prominent biotech hedge fund that manages about $9 billion, lost about 30% this year through November in its main fund, investors say. A hedge fund managed by OrbiMed Partners, which invests more than $18 billion in healthcare in public and private markets, has lost more than 40% this year through November…

…The SPDR S&P Biotech ETF (XBI), an equal-weighted index of biotech stocks, has fallen about 22% so far this year through Friday, and is down 37% from its Feb. 8 peak.

Unquote

2) why did we issue more shares to raise money and cause unecessary dilution?

Companies raise whenever they can, not necessarily when they need.
Am i happy? No, but i still hold my shares!